## Core Concept
The autoregulation of renal blood flow is a critical mechanism that maintains a relatively constant renal blood flow over a wide range of arterial blood pressures. This process involves the constriction and dilation of renal blood vessels in response to changes in blood pressure, ensuring that the kidneys receive an adequate blood supply for filtration and function. Various pharmacological agents and physiological conditions can influence this autoregulatory mechanism.

## Why the Correct Answer is Right
Prostaglandins, particularly those of the prostaglandin I (PGI) and prostaglandin E (PGE) series, play a role in modulating renal vascular tone and can influence autoregulation. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin synthesis, which can impair renal autoregulation by reducing the ability of the kidneys to dilate or constrict in response to changes in blood pressure. On the other hand, **Angiotensin II** actually helps in maintaining renal autoregulation by causing vasoconstriction at low blood pressure levels, thus supporting the maintenance of glomerular filtration rate (GFR) within a certain range of blood pressures.

## Why Each Wrong Option is Incorrect
- **Option A:** NSAIDs can impair renal autoregulation by inhibiting prostaglandin synthesis, which is crucial for the kidneys' ability to adjust to changes in blood pressure.
- **Option B:** ACE inhibitors can also affect renal autoregulation indirectly by reducing Angiotensin II levels, which play a role in maintaining GFR under conditions of low blood pressure.
- **Option C:** Calcium channel blockers can interfere with renal autoregulation by affecting the contractility of vascular smooth muscle, thereby influencing the kidney's ability to adjust vascular resistance in response to blood pressure changes.

## Clinical Pearl / High-Yield Fact
A key clinical point to remember is that **NSAIDs can precipitate acute kidney injury (AKI) in certain settings**, such as in patients with pre-existing renal disease, heart failure, or those taking other nephrotoxic agents, partly due to their effect on renal autoregulation.

## Correct Answer: D. Angiotensin II.